Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Chiou, Shih Hwa ^a   Kao, Chung Lan ^a   Chen, Yi Wei ^a   Chien, Chien Shu ^a   Hung, Shih Chieh ^a   Lo, Jeng Fan ^a   Chen, Yann Jang ^a   Ku, Hung Hai ^a   Hsu, Ming Ta ^a   Wong, Tai Tong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CD133 ANTIGEN; CELL PROTEIN; CISPLATIN; COMPLEMENTARY DNA; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN BCL 2; PROTEIN CHX2; PROTEIN RAD17; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATYPICAL TERATOID RHABDOID TUMOR; CANCER GROWTH; CANCER STEM CELL; CELL CYCLE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; FEMALE; GENE CLUSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; SCID MOUSE; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; GENETICS; IMMUNOLOGY; INFANT; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PRESCHOOL CHILD; RADIATION DOSE; RADIATION EXPOSURE; RHABDOID TUMOR;

MUS;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; DNA REPAIR; FEMALE; GLYCOPROTEINS; HUMANS; INFANT; MALE; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; PEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RADIATION, IONIZING; RHABDOID TUMOR; RNA, SMALL INTERFERING;

EID: 47749106106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002090     Document Type: Article

References (45)

1. Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J Neurosurg 85: 56-65.
2. Burger PC, Yu IT, Tihan T, et al. (1998) Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study. Am J Surg Pathol 22: 1083-1092.
3. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, et al. (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23: 1491-1499.
4. Wong TT, Ho DM, Chang KP, et al. (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 104: 2156-2167.
5. Packer RJ, Biegel JA, Blaney S, et al. (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 24: 337-342.
6. Parwani AV, Stelow EB, Pambuccian SE, Burger PC, Ali SZ (2005) Atypical teratoid/rhabdoid tumor of the brain: cytopathologic characteristics and differential diagnosis. Cancer 105: 65-70.
7. Cheng YC, Lirng JF, Chang FC, et al. (2005) Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system. Acta Radiol 46: 89-96.
8. Weiss E, Behring B, Behnke J, et al. (1998) Treatment of primary malignant tumor of the brain: Report of three cases and review of the literature. Int J Radiat Oncol Biol Phys 41: 1013-1019.
9. Hilden JM, Meerbaum S, Burger P, et al. (2004) Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 22: 2877-2884.
10. Chen YW, Wong TT, Ho DM, et al. (2006) Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64: 103810-103843.
11. Biegel JA, Rorke LB, Emanuel BS (1989) Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. N Engl J Med 321: 906-9.
12. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442.
13. Bergmann M, Spaar HJ, Ebhard G, et al. (1997) Primary malignant rhabdoid tumors of the central nervous system: an immunohistochemical and ultrastructural study.
14. Ho DMT, Hsu CY, Wong TT, et al. (2000) Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol (Berl) 99: 482-488.
15. Biegel JA, Burk CD, Parmiter, et al. (1992) Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Gene Chromosomes Cancer 5: 104-108.
16. Biegel JA, Allen CS, Kawasaki K, et al. (1996) Narrowing the critical region for a rhabdoid tumor focus in 22q11. Gene Chromosomes Cancer 16: 94-105.
17. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, et al. (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59: 74-79.
18. Versteege I, Sevenet N, Lange J, et al. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394: 203-206.
19. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
20. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, et al. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100: 15178-15183.
21. Singh SK, Hawkins C, Clarke ID, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
22. Neuzil J, Stantic M, Zobalova R, et al. (2007) Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 355: 855-859.
23. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
24. Bao S, Wu Q, McLendon RE, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. Acta Neurochir (Wien) 139: 961-969.
25. + sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 67: 1-5.
26. Lin HL, Yang MH, Wu CW, et al. (2007) 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Int J Cancer 121: 2547-2555.
27. Peng CH, Chiou SH, Chen SJ, et al. (2008) Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. European Neuropsych 18: 128-140.
28. Zeppernick F, Ahmadi R, Campos B, et al. (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129.
29. - glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
30. Chang HJ, Maj JG, Paris F, et al. (2005) ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 11: 484-490.
31. Zgheib O, Huyen Y, DiTullio JRA, et al. (2005) ATM signaling and 53BP1. Radiother Oncol 76: 119-122.
32. Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31: 402-410.
33. Mirzayans R, Severin D, Murray D (2006) Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: Implications for evaluation of clinical radiosensitivity. Int J Radiat Oncol Biol Phys 66: 1498-1505.
34. Cartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
35. Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 33: 851-858.
36. Choudhury AR, Ju Z, Djojosubroto MW, et al. (2007) Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nature Genetics 39: 99-105.
37. Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923.
38. Duan W, Gao L, Wu X, Zhang Y, Otterson GA, et al. (2006) Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. Exp Cell Res 312: 3370-3378.
39. Nix P, Cawkwell L, Patmore H, et al. (2005) Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer 92: 2185-2189.
40. Schwartz JL, Jordan R, Slovic J, et al. (2007) Induction and loss of a TP53-dependent radioadaptive response in the human lymphoblastoid cell model TK6 and its abrogation by BCL2 over-expression. Int J Radiat Biol 83: 153-159.
41. Fan C, Quan R, Feng X, et al. (2006) ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochim Biophys Acta 1763: 1090-1097.
42. Chiou SH, Yang YP, Lin JC, et al. (2006a) Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br J Pharmacol 148: 587-598.
43. Kao CL, Chiou SH, Chen YJ, et al. (2005) Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mol Pathol 18: 769-778.
44. Yang MH, Chang SY, Chiou SH, et al. (2007) Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Sanil predicts metastatsis of head and neck cancer. Oncogene 26: 1459-1467.
45. Chiou SH, Yang YP, Lin JC, et al. (2006b) The immediate early 2 protein of cytomegalovirus controls apoptosis in human retina by activating cellular FLICE-inhibitory protein. J Immunol 177: 6199-6206.